Erratum: Blood clot formation does not affect metastasis formation or tumor growth in a murine model of breast cancer( PLoS ONE (2014) 9, 4 (e94922) DOI: 10.1371/journal.pone.0094922);Blood clot formation does not affect metastasis formation or tumor growth in a murine model of breast cancer

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Rossnagl, Stephanie ^a,b   Von Au, Anja ^a,b   Vasel, Matthaeus ^a,b   Cecchini, Arco G ^c   Nakchbandi, Inaam A ^a,b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BONE EROSION; BONE MARROW; BONE TURNOVER; BREAST CANCER; CANCER CELL; CANCER CELL LINE; CANCER INFILTRATION; CELL COUNT; CELL HOMING; DISEASE ASSOCIATION; HEMATOMA; HUMAN; HUMAN CELL; INTRATIBIAL HEMATOMA; METASTASIS; MICROSCOPY; MORPHOMETRICS; MURINE MODEL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; TIBIA; TUMOR GROWTH; ANIMAL; BONE TUMOR; BREAST TUMOR; DISEASE MODEL; FEMALE; FLOW CYTOMETRY; GENETICS; KNOCKOUT MOUSE; LUMINESCENCE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; THROMBOSIS; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

LUCIFERASE; TUMOR MARKER;

ANIMALS; BLOOD COAGULATION; BONE MARROW; BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HEMATOMA; HUMANS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; MICE, KNOCKOUT; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOSIS; TIBIA; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84899741964     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103911     Document Type: Erratum

References (51)

1. Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27: 165-176. (Pubitemid 32452017)
2. Benoy IH, Elst H, Philips M, Wuyts H, VanDam P, et al. (2006) Real-time RTPCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. Br J Cancer 94: 672-680. (Pubitemid 43361898)
3. Wood DP Jr, Banks ER, Humphreys S, McRoberts JW, Rangnekar VM (1994) Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74: 2533-2540. (Pubitemid 24320859)
4. Bussard KM, Gay CV, Mastro AM (2008) The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Rev 27: 41-55.
5. Lipton A (2010) Bone continuum of cancer. Am J Clin Oncol 33: S1-S7.
6. Melton LJ 3rd, Hartmann LC, Achenbach SJ, Atkinson EJ, Therneau TM, et al. (2012) Fracture risk in women with breast cancer: A population-based study. J Bone Miner Res.
7. Snell W, Beals RK (1964) Femoral Metastases and Fractures from Breast Cancer. Surg Gynecol Obstet 119: 22-24.
8. Body JJ (2011) Increased fracture rate in women with breast cancer: A review of the hidden risk. BMC Cancer 11: 384.
9. Green D, Karpatkin S (2010) Role of thrombin as a tumor growth factor. Cell Cycle 9: 656-661.
10. Palumbo JS, Barney KA, Blevins EA, Shaw MA, Mishra A, et al. (2008) Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function. J Thromb Haemost 6: 812-819. (Pubitemid 351524542)
11. Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, et al. (2000) Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96: 3302-3309.
12. Rak J, Milsom C, May L, Klement P, Yu J (2006) Tissue factor in cancer and angiogenesis: The molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost 32: 54- 70.
13. Garnier D, Milsom C, Magnus N, Meehan B, Weitz J, et al. (2010) Role of the tissue factor pathway in the biology of tumor initiating cells. Thromb Res 125 Suppl 2: S44-S50.
14. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, et al. (2006) Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrowderived progenitor cells to arterial thrombi in vivo. J Exp Med 203: 1221-1233. (Pubitemid 43736592)
15. Nakchbandi W, Muller H, Singer MV, Lohr JM, Nakchbandi IA (2008) Prospective study on warfarin and regional chemotherapy in patients with pancreatic carcinoma. J Gastrointestin Liver Dis 17: 285-290.
16. Nakchbandi IA, Lohr JM (2008) Coagulation, anticoagulation and pancreatic carcinoma. Nat Clin Pract Gastroenterol Hepatol 5: 445-455.
17. Hirshberg A, Leibovich P, Horowitz I, Buchner A (1993) Metastatic tumors to postextraction sites. J Oral Maxillofac Surg 51: 1334-1337. (Pubitemid 23358295)
18. Wetterwald A, vanderPluijm G, Que I, Sijmons B, Buijs J, et al. (2002) Optical imaging of cancer metastasis to bone marrow: A mouse model of minimal residual disease. Am J Pathol 160: 1143-1153. (Pubitemid 34224600)
19. vonAu A, Vasel M, Kraft S, Sens C, Hackl N, et al. (2013) Circulating fibronectin controls tumor growth. Neoplasia 15: in press.
20. Bentmann A, Kawelke N, Moss D, Zentgraf H, Bala Y, et al. (2010) Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function. J Bone Miner Res 25: 706-715.
21. Kawelke N, Bentmann A, Hackl N, Hager HD, Feick P, et al. (2008) Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation. J Bone Miner Res 23: 1278-1286. (Pubitemid 352040182)
22. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
23. Kawamoto T (2003) Use of a new adhesive film for the preparation of multipurpose fresh-frozen sections from hard tissues, whole-animals, insects and plants. Arch Histol Cytol 66: 123-143. (Pubitemid 36834422)
24. Baron R, Vignery A, Neff L, Silvergate A, Santa Maria A (1983) Processing of undecalcified bone specimens for bone histomorphometry. In: Recker R, editor. Bone Histomorphometry: Techniques and Interpretations Boca Raton, FL, USA: CRC Press Inc.
25. Cosby CN, Troiano NW, Kacena MA (2008) The Effects of Storage Conditions on the Preservation of Enzymatic Activity in Bone. J Histotechnol 31: 169-173.
26. Xue Y, Xiao Y, Liu J, Karaplis AC, Pollak MR, et al. (2012) The calciumsensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice. Am J Physiol Endocrinol Metab 302: E841-E851.
27. Havens AM, Pedersen EA, Shiozawa Y, Ying C, Jung Y, et al. (2008) An in vivo mouse model for human prostate cancer metastasis. Neoplasia 10: 371-380.
28. vanderPluijm G, Que I, Sijmons B, Buijs JT, Lowik CW, et al. (2005) Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo. Cancer Res 65: 7682-7690. (Pubitemid 41297242)
29. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593. (Pubitemid 37328925)
30. Hannink M, Donoghue DJ (1989) Structure and function of platelet-derived growth factor (PDGF) and related proteins. Biochim Biophys Acta 989: 1-10. (Pubitemid 19180347)
31. Wartiovaara U, Salven P, Mikkola H, Lassila R, Kaukonen J, et al. (1998) Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 80: 171-175. (Pubitemid 28353517)
32. Kowalska MA, Ratajczak MZ, Majka M, Jin J, Kunapuli S, et al. (2000) Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets. Blood 96: 50-57. (Pubitemid 30456449)
33. Gazitt Y (2004) Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatment with chemotherapy and antilineage-specific antibodies. Leukemia 18: 1-10. (Pubitemid 38159432)
34. Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M (1994) PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF betareceptors. J Cell Biol 125: 917-928. (Pubitemid 24151185)
35. Nor JE, Christensen J, Mooney DJ, Polverini PJ (1999) Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154: 375-384. (Pubitemid 29094088)
36. Fradet A, Sorel H, Bouazza L, Goehrig D, Depalle B, et al. (2011) Dual function of ERRalpha in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Res 71: 5728-5738.
37. Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J (1972) Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136: 261-276.
38. Nieswandt B, Hafner M, Echtenacher B, Mannel DN (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59: 1295-1300. (Pubitemid 29136261)
39. Li X, Koh AJ, Wang Z, Soki FN, Park SI, et al. (2011) Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis. J Bone Miner Res 26: 125-134.
40. Suva LJ, Seedor JG, Endo N, Quartuccio HA, Thompson DD, et al. (1993) Pattern of gene expression following rat tibial marrow ablation. J Bone Miner Res 8: 379-388. (Pubitemid 23095903)
41. Bussard KM, Venzon DJ, Mastro AM (2010) Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer. J Cell Biochem 111: 1138-1148.
42. Obata NH, Tamakoshi K, Shibata K, Kikkawa F, Tomoda Y (1997) Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma. Anticancer Res 17: 337-342. (Pubitemid 27116689)
43. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, et al. (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96: 34-40. (Pubitemid 30456447)
44. Buijs JT, Stayrook KR, Guise TA (2011) TGF-beta in the Bone Microenvironment: Role in Breast Cancer Metastases. Cancer Microenviron 4: 261-281.
45. Nakchbandi IA, Mitnick MA, Masiukiewicz US, Sun BH, Insogna KL (2001) IL-6 negatively regulates IL-11 production in vitro and in vivo. Endocrinology 142: 3850-3856. (Pubitemid 32802656)
46. Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, et al. (1999) Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265: 144-150.
47. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD (1989) Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res 4: 113-118. (Pubitemid 19079131)
48. Nunamaker DM (1998) Experimental models of fracture repair. Clin Orthop Relat Res: S56-s65.
49. Shiozawa Y, Pedersen EA, Havens AM, Jung Y, Mishra A, et al. (2011) Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest 121: 1298-1312.
50. Sugiyama T, Kohara H, Noda M, Nagasawa T (2006) Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25: 977-988. (Pubitemid 44894948)
51. Phadke PA, Mercer RR, Harms JF, Jia Y, Frost AR, et al. (2006) Kinetics of metastatic breast cancer cell trafficking in bone. Clin Cancer Res 12: 1431- 1440.